Hirsutinolide-type sesquiterpenoids with anti-prostate cancer activity from Cyanthillium cinereum

Phytochemistry. 2023 Dec:216:113887. doi: 10.1016/j.phytochem.2023.113887. Epub 2023 Oct 6.

Abstract

Four previously undescribed hirsutinolide-type sesquiterpenoids, cyanolides A-D (1-4), along with twelve known analogues (5-16), were isolated from the aerial parts of Cyanthillium cinereum. Their structures were determined by comprehensive analysis of NMR, HRESIMS, and ECD spectra. Compound 1 is a rarely occurring hirsutinolide-type sesquiterpenoid with 1,4-ether ring ruptured and containing a chlorine atom, and compounds 13-16 were reported from this plant for the first time. All compounds were tested for their inhibiting effects on prostate cancer cells. As a result, compounds 1, 3, and 8-14 exhibited significant anti-prostate cancer activity against PC-3 and LNCaP cells with IC50 values ranging from 2.2 ± 0.4 to 8.5 ± 0.7 μM and 3.0 ± 0.7 to 10.5 ± 1.1 μM, respectively. The preliminary structure-activity relationship was discussed. Further investigation showed that compound 1 induced apoptosis in PC-3 cells.

Keywords: Anti-prostate cancer activity; Cyanthillium cinereum (L.) (Asteraceae); Hirsutinolide-type sesquiterpenoid.

MeSH terms

  • Asteraceae* / chemistry
  • Humans
  • Male
  • Molecular Structure
  • Prostatic Neoplasms* / drug therapy
  • Sesquiterpenes* / chemistry
  • Sesquiterpenes* / pharmacology
  • Structure-Activity Relationship

Substances

  • Sesquiterpenes